Chengda Biological: Wholly owned subsidiary passes drug GMP compliance inspection

Chengda Biology Announcement: Its wholly-owned subsidiary, Chengda Biology (Benxi) Co., Ltd., recently received the “Notice of On-site Inspection Results for GMP Compliance” issued by the Liaoning Provincial Drug Administration. The production facility of the Benxi subsidiary has passed the Good Manufacturing Practice (GMP) compliance inspection for the production of human rabies vaccine (human diploid cell).

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin